Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis

[1] Degenhardt L(2017)Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review Lancet Glob Health 5 e1192-e1207

[2] Peacock A(2015)Population size estimates for men who have sex with men and persons who inject drugs J Urban Health 92 733-743

[3] Colledge S(2018)Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014 Am J Public Health 108 175-181

[4] Leung J(2016)Endocarditis as a marker for new epidemics of injection drug use Am J Med Sci 352 609-614

[5] Grebely J(2016)Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis Am J Med 129 481-485

[6] Vickerman P(2017)Short- and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis BMC Cardiovasc Disord 17 291-204

[7] Oster AM(2006)Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients BMC Infect Dis 6 137-575

[8] Sternberg M(2007)In-hospital and long-term mortality in infective endocarditis in injecting drug users compared to non-drug users: a retrospective study of 192 episodes Scand J Infect Dis 39 197-5

[9] Lansky A(2014)Repeat endocarditis: analysis of risk factors based on the international collaboration on endocarditis – prospective cohort study Clin Microbiol Infect 20 566-1486

[10] Broz D(2017)The cost of a recalcitrant intravenous drug user with serial cases of endocarditis: need for guidelines to improve the continuum of care IDCases. 8 3-372

[1] Degenhardt L(2017)Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review Lancet Glob Health 5 e1192-e1207

[2] Peacock A(2015)Population size estimates for men who have sex with men and persons who inject drugs J Urban Health 92 733-743

[3] Colledge S(2018)Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014 Am J Public Health 108 175-181

[4] Leung J(2016)Endocarditis as a marker for new epidemics of injection drug use Am J Med Sci 352 609-614

[5] Grebely J(2016)Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis Am J Med 129 481-485

[6] Vickerman P(2017)Short- and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis BMC Cardiovasc Disord 17 291-204

[7] Oster AM(2006)Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients BMC Infect Dis 6 137-575

[8] Sternberg M(2007)In-hospital and long-term mortality in infective endocarditis in injecting drug users compared to non-drug users: a retrospective study of 192 episodes Scand J Infect Dis 39 197-5

[9] Lansky A(2014)Repeat endocarditis: analysis of risk factors based on the international collaboration on endocarditis – prospective cohort study Clin Microbiol Infect 20 566-1486

[10] Broz D(2017)The cost of a recalcitrant intravenous drug user with serial cases of endocarditis: need for guidelines to improve the continuum of care IDCases. 8 3-372